UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000037968 |
|---|---|
| Receipt number | R000043212 |
| Scientific Title | Comprehensive analysis of bronchoalveolar lavage fluid in diffuse lung diseases |
| Date of disclosure of the study information | 2019/09/09 |
| Last modified on | 2021/09/11 07:13:57 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Comprehensive analysis of bronchoalveolar lavage fluid in diffuse lung diseases
Acronym
Comprehensive analysis of bronchoalveolar lavage fluid in diffuse lung diseases
Scientific Title
Comprehensive analysis of bronchoalveolar lavage fluid in diffuse lung diseases
Scientific Title:Acronym
Comprehensive analysis of bronchoalveolar lavage fluid in diffuse lung diseases
Region
| Japan |
Condition
Condition
Diffuse lung disease
Classification by specialty
| Pneumology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To investigate pathology of various diffuse lung diseases
Basic objectives2
Others
Basic objectives -Others
To investigate pathology of various diffuse lung diseases
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Comprehensive analysis of various elements in bronchoalveolar lavage fluid
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Subjects who undertook bronchoscopy due to their diffuse lung disease
Key exclusion criteria
Under 20 years old
Target sample size
90
Research contact person
Name of lead principal investigator
| 1st name | Shonosuke |
| Middle name | |
| Last name | Tajima |
Organization
Kawasaki Medical School
Division name
Respiratory Medicine
Zip code
701-0162
Address
577 matsushima, Kurashiki city
TEL
086-462-1111
shonosuke@med.kawasaki-m.ac.jp
Public contact
Name of contact person
| 1st name | Shonosuke |
| Middle name | |
| Last name | Tajima |
Organization
Kawasai Medical School
Division name
Respiratory Medicine
Zip code
700-0162
Address
577 matsushima, Kurashiki city
TEL
086-462-1111
Homepage URL
shonosuke@med.kawasaki-m.ac.jp
Sponsor or person
Institute
Kawasaki Medical School
Institute
Department
Personal name
Funding Source
Organization
None
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Kawasaki Medical School ethics committee
Address
577 matsushima, Kurashiki city
Tel
086-464-1076
Kmsrec@med.kawasaki-m.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2019 | Year | 09 | Month | 09 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
95
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
No longer recruiting
Date of protocol fixation
| 2019 | Year | 10 | Month | 01 | Day |
Date of IRB
| 2019 | Year | 11 | Month | 11 | Day |
Anticipated trial start date
| 2019 | Year | 10 | Month | 01 | Day |
Last follow-up date
| 2021 | Year | 10 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
The subject is a person who performs bronchoscopy for diffuse lung disease over the age of 20 years. If consent is obtained, use bronchoalveolar lavage fluid and blood samples.The recrusent period is when 90 cases of the planned number of cases are gathered.
Management information
Registered date
| 2019 | Year | 09 | Month | 09 | Day |
Last modified on
| 2021 | Year | 09 | Month | 11 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043212
